Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.

Expert review of molecular diagnostics - 1 Jul 2012

Ong Frank S, Das Kingshuk, Wang Jay, Vakil Hana, Kuo Jane Z, Blackwell Wendell-Lamar B, Lim Stephen W, Goodarzi Mark O, Bernstein Kenneth E, Rotter Jerome I, Grody Wayne W

Abstract excerpt

In the field of oncology, clinical molecular diagnostics and biomarker discoveries are constantly advancing as the intricate molecular mechanisms that transform a normal cell into an aberrant state in concert with the dysregulation of alternative complementary pathways are increasingly understood. Progress in biomarker technology, coupled with the companion clinical diagnostic laboratory tests, continue to...

Topics

Join the communities discussing this publication.

Antineoplastic Agents
Biomarkers, Tumor
EML4 gene
Genetic Testing
Molecular Diagnostic Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 22845480
DOI: 10.1586/erm.12.59
PMCID: PMC3495985

Genes

ALK
BCR
BRAF
EGFR
EML4
ERBB2
KRAS
PML

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.PMID 22845480Read ↗

Molecular Testing for Diagnostics, Prognostication, and Treatment Stratification in Cancers.Semantic proximity Read ↗

Clinically relevant cancer biomarkers and pharmacogenetic assays.Semantic proximity Read ↗

Molecular diagnostics and personalized medicine in oncology: challenges and opportunities.Semantic proximity Read ↗

Molecular profiling of cancer--the future of personalized cancer medicine: a primer on cancer biology and the tools necessary to bring molecular testing to the clinic.Semantic proximity Read ↗

Pan-Cancer Biomarkers: Changing the Landscape of Molecular Testing.Semantic proximity Read ↗

Advances in Personalized OncologySemantic proximity Read ↗

Companion biomarkers: paving the pathway to personalized treatment for cancer.Semantic proximity Read ↗

The molecular pathology of cancer.Semantic proximity Read ↗

Special report: multiple molecular testing of cancers to identify targeted therapies.Semantic proximity Read ↗

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug ResistanceSemantic proximity Read ↗

Use of molecular markers for predicting therapy response in cancer patients.Semantic proximity Read ↗

Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized MedicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.